Legal notice
Site ownership
The site adenofrin.net is operated by the team of Adenofrin India, with address at Office No. 1207, 12th Floor, One BKC, G-Block, Mumbai — 400051, Maharashtra, India. All information presented on this site is intended for the adult Indian audience and does not constitute personalised medical consultation.
Product nature
Adenofrin is a nutraceutical food supplement as per the Food Safety and Standards Act 2006 and FSSAI Nutraceuticals Regulations 2022, notified to the Food Safety and Standards Authority of India (FSSAI). It is not a medicine, does not require a prescription, has no therapeutic indications, and does not replace treatment prescribed by a urologist, general physician or specialist.
Limitation of liability
The information presented on adenofrin.net has educational and commercial purposes. The manufacturer assumes no liability for misuse of the product, dosages exceeding those indicated on the label, self-medication for already-diagnosed urological conditions or for failure to consult a healthcare professional in the presence of active drug therapy. The customer reviews published on the site are individual testimonials and do not constitute a guarantee of result.
Trademarks and intellectual property
The trademark "Adenofrin", logo, packaging, texts, images, graphic composition and content of the site are the exclusive property of the owner. Any reproduction, modification, publication or commercial use, even partial, is prohibited without written authorisation. Third-party trademarks cited on comparison pages (Apollo Pharmacy, Tata 1mg, PharmEasy, Netmeds, Amazon, Flipkart Health+, etc.) belong to their respective owners and are used only for descriptive and informational purposes.
Applicable law and jurisdiction
These legal notices, contractual relations and data processing policies are governed by Indian law, including the Consumer Protection Act 2019, the Indian Contract Act 1872, the Information Technology Act 2000, the Digital Personal Data Protection Act 2023 (DPDP Act) and the Food Safety and Standards Act 2006. For any dispute, the consumer may approach the District Consumer Disputes Redressal Commission having jurisdiction over the consumer's place of residence in India.
FSSAI compliance and nutraceutical regulatory framework
Adenofrin is manufactured and marketed in India in conformity with the Food Safety and Standards Act, 2006 (Act No. 34 of 2006), administered by the Food Safety and Standards Authority of India (FSSAI), FDA Bhawan, Kotla Road, New Delhi 110002, www.fssai.gov.in. The product category falls under the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, and Prebiotic and Probiotic Food) Regulations, 2022, replacing the 2016 Regulations. Each manufacturing batch is allotted a 14-digit FSSAI Licence number visible on the carton, and the product is labelled in accordance with the Food Safety and Standards (Labelling and Display) Regulations, 2020, including the mandatory FSSAI logo, batch number, manufacturing date, best before date, vegetarian/non-vegetarian green/brown dot, and the cautionary statement "Not for medicinal use" as required by Schedule II of the Nutraceutical Regulations.
E-commerce compliance — IT Act and IT Rules 2021
The website adenofrin.net operates as an intermediary under the Information Technology Act, 2000 (Act No. 21 of 2000), and complies with the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Rules, 2021, as amended in 2022 and 2023. We publish prominently the grievance officer details, observe due diligence by publishing our Rules and Regulations, Privacy Policy and User Agreement, and respond to government notices within the stipulated 72 hours. Additionally, we are subject to the Consumer Protection (E-Commerce) Rules, 2020 framed under Section 101 of the Consumer Protection Act, 2019, which prescribe mandatory disclosures of seller details, country of origin, total price, refund and return policies, and grievance redressal mechanisms.
GST registration and tax compliance
As a registered taxable entity under the Central Goods and Services Tax Act, 2017 (Act No. 12 of 2017) and the Maharashtra Goods and Services Tax Act, 2017, we issue tax invoices in compliance with Rule 46 of the CGST Rules, including the GSTIN, HSN code applicable to nutraceuticals (HSN 2106 for food preparations) and the applicable rate of GST. Returns are filed monthly through the GST portal (gst.gov.in). For B2C transactions valued above INR 50,000, customer GSTIN is captured where applicable for Input Tax Credit eligibility.
Bilingual content and accessibility
While the principal content of adenofrin.net is published in English in line with the Official Languages Act, 1963 and customary usage in pan-Indian e-commerce, key safety information (warnings, dosage, side effects) and the order confirmation script used by our phone team are also communicated in Hindi (हिन्दी) upon request, to comply with Rule 5(1)(a) of the IT Rules 2021 mandating that grievances may be filed in the language of the user's choice. Regional language support (Marathi, Tamil, Telugu, Bengali, Gujarati, Kannada, Malayalam, Punjabi) is provided on a best-effort basis through the phone helpline.
Disputes and CCPA jurisdiction
In the event of false or misleading advertisements, the Central Consumer Protection Authority (CCPA), established under Section 10 of the Consumer Protection Act, 2019, has the power to issue directions to discontinue the advertisement and impose penalties up to INR 50 lakh under Section 21. We commit to immediate corrective action on receipt of any CCPA notice. Subject to the jurisdiction of the District Consumer Commission elected by the consumer, the courts at Mumbai, Maharashtra shall otherwise have jurisdiction under Section 20 of the Code of Civil Procedure, 1908.
